Literature DB >> 19838519

Pain in tropical spastic paraparesis/HTLV-I associated myelopathy patients.

Carlos Maurício de Castro-Costa1, Abelardo de Queiroz Campos Araújo, Carlos C Câmara, Ayrton S Ferreira, Terezinha de Jesus T Santos, Samuel Bovy de Castro-Costa, Raimundo Neudson M Alcântara, Graham P Taylor.   

Abstract

OBJECTIVE: Tropical Spastic Paraparesis/HTLV-I Associated Myelopathy (TSP/HAM) is a chronic myelopathy, and pain has been mentioned as a frequent sensory symptom in this condition. The authors aimed at analyzing this symptom in a TSP/HAM patients series.
METHOD: For this, 46 patients were analyzed considering demographic and clinical characteristics and complaint of pain as to verbal description, time of onset and classification, correlated with the degree of motor disability and type of pain.
RESULTS: Among the 46 TSP/HAM patients, 28 (60.8%) complained of pain, predominant in the early phase of the disease. Most of the patients exhibited neuropathic characteristics of pain, correlated with increased motor disability.
CONCLUSION: Pain in TSP/HAM patients is a frequent and early symptom, and the neuropathic type is predominant (57.1%) and paralleled with increased incapacitation. The pathogenic involvement of cytokines may possibly be involved in the meaning of this symptom in this condition.

Entities:  

Mesh:

Year:  2009        PMID: 19838519     DOI: 10.1590/s0004-282x2009000500016

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  7 in total

1.  Case Report: Cognitive Impairment without Clinical Spinal Disease May Be the First Sign of HTLV-1 Neurological Alteration.

Authors:  Aline Rejane Rosa de Castro; Ludimila Labanca; Luciana Macedo de Resende; Denise Utsch-Gonçalves
Journal:  Am J Trop Med Hyg       Date:  2020-02       Impact factor: 2.345

2.  Pain, psychoaffective symptoms, and quality of life in human T cell lymphotropic virus type 1 (HTLV-1): a cross-sectional study.

Authors:  Dislene Nascimento Dos Santos; Katia Nunes Sá; Fernanda C Queirós; Alaí Barbosa Paixão; Kionna Oliveira Bernardes Santos; Rosana Cristina Pereira de Andrade; Janine Ribeiro Camatti; Abrahão Fontes Baptista
Journal:  J Neurovirol       Date:  2021-01-06       Impact factor: 2.643

Review 3.  HTLV-1, Immune Response and Autoimmunity.

Authors:  Juarez A S Quaresma; Gilberto T Yoshikawa; Roberta V L Koyama; George A S Dias; Satomi Fujihara; Hellen T Fuzii
Journal:  Viruses       Date:  2015-12-24       Impact factor: 5.048

4.  Occupational Therapy for People Living With Human T-Lymphotropic Virus 1: Importance and Effectiveness of an Intervention Plan at the Level of Prevention and Rehabilitation.

Authors:  Edilson Coelho Sampaio; Cintia Yolette Urbano Pauxis Aben-Athar; Denise da Silva Pinto; Antonio Carlos Rosário Vallinoto; Izaura Maria Vieira Cayres Vallinoto
Journal:  Front Med (Lausanne)       Date:  2022-03-29

5.  Effect of Pulsed Methylprednisolone on Pain, in Patients with HTLV-1-Associated Myelopathy.

Authors:  Kevin G Buell; Aiysha Puri; Maria Antonietta Demontis; Charlotte L Short; Adine Adonis; Jana Haddow; Fabiola Martin; Divya Dhasmana; Graham P Taylor
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

6.  Factors associated with pain in individuals infected by human T-cell lymphotropic virus type 1 (HTLV-1).

Authors:  Dislene N Dos Santos; Kionna O B Santos; Alaí B Paixão; Rosana Cristina P de Andrade; Davi T Costa; Daniel L S-Martin; Katia N Sá; Abrahão F Baptista
Journal:  Braz J Infect Dis       Date:  2016-12-21       Impact factor: 3.257

Review 7.  Pain prevalence, characteristics and associated factors in human T-cell lymphotropic virus type 1 infected patients: a systematic review of the literature.

Authors:  Daniel Lordelo San-Martin; Dislene Nascimento Dos Santos; Abrahão Fontes Baptista
Journal:  Braz J Infect Dis       Date:  2016-10-18       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.